SWORD Health Stock

Sword Health, a physical therapy start-up, is strategically focusing on artificial intelligence ahead of a potential IPO. The company aims to triple its AI team and is open to making acquisitions to spur growth. CEO Virgilio Bento plans to take the company public after it achieves profitability, which is expected in 2024.

Growing up, Virgilio Bento watched his older brother suffer an accident and struggle to access the intensive physical therapy he needed to recover. Bento has since dedicated his career to solving pain for the two billion people around the globe who suffer each year. In 2015, he started Sword Health to free the world from pain and has helped thousands of people along the way.

Aspect Biosystems and Novo Nordisk are collaborating on a $2.6 billion project to develop therapeutics for type 1 diabetes and obesity. The companies aim to create 3D, biologically functional tissues containing insulin-producing cells that can be implanted without the need for immunosuppressive drugs. The partnership will fund up to four products for the treatment of diabetes and/or obesity, with Aspect eligible to receive up to $650 million per project based on future milestones, plus royalties on product sales.